IP Library Granted Patent US 11,351,349
Granted Patent B2
US 11,351,349 · App. 16/548,514 · Granted Jun 7, 2022

Using alternating electric fields to increase permeability of the blood brain barrier

Inventors: Carsten Hagemann (Unterpleichfeld, DE); Mario Lohr (Dillenburg, DE); Almuth F. Kessler (Reichenberg, DE); Malgorzata Burek (Wurzburg, DE); Carola Forster (Wurzburg, DE); Catherine Brami (Matan, IL); Hadas Sara Hershkovich (Kiryat Motzkin, IL); Tali Voloshin-Sela (Kibbutz Gvat, IL)
Assignee: Novocure GmbH
A61M37/0092A61K9/0009A61N1/325A61N1/327A61N1/36002A61N1/3603A61N1/37217A61K9/0085A61M2037/0007A61M2202/0007A61M2210/0693A61M2250/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,351,349
App. No.
16/548,514
Granted
Jun 7, 2022
Kind
B2
Abstract

Certain substances (e.g., large molecules) that ordinarily cannot traverse the blood brain barrier can be introduced into the brain by applying an alternating electric field to the brain for a period of time, wherein the frequency of the alternating electric field is selected so that application of the alternating electric field increases permeability of the blood brain barrier. In some embodiments, the frequency of the alternating electric field is less than 190 kHz (e.g., 100 kHz). Once the permeability of the blood brain barrier has been increased, the substance is able to cross the blood brain barrier.

Claims (19)

1. A method for delivering a substance across a blood brain barrier of a subject's brain, the method comprising:

applying an alternating electric field to the subject's brain for a period of time, wherein application of the alternating electric field to the subject's brain for the period of time increases permeability of the blood brain barrier in the subject's brain, and wherein the subject's brain is tumor-free; and

administering the substance to the subject after the period of time has elapsed, wherein the increased permeability of the blood brain barrier allows the substance to cross the blood brain barrier,

wherein the period of time is at least 24 hours.

2. The method of claim 1 , wherein the alternating electric field is applied at a frequency between 75 kHz and 125 kHz.

3. The method of claim 1 , wherein the period of time is at least 48 hours.

4. The method of claim 1 , wherein the alternating electric field has a field strength of at least 1 V/cm in at least a portion of the subject's brain.

5. The method of claim 1 , wherein the alternating electric field is applied at a frequency between 75 kHz and 125 kHz and the alternating electric field has a field strength of at least 1 V/cm in at least a portion of the subject's brain.

6. The method of claim 1 , further comprising discontinuing the application of the alternating electric field to allow the blood brain barrier to recover.

7. The method of claim 1 , wherein the substance has a molecular weight between 4 kDa and 69 kDa.

8. The method of claim 1 , wherein the step of applying an alternating electric field to the subject's brain is implemented by applying an AC voltage to a set of electrodes.

9. A method for delivering a substance across a blood brain barrier of a subject's brain, the method comprising:

applying an alternating electric field at a first frequency to the subject's brain for a period of time, wherein the first frequency is less than 190 kHz and the period of time is at least 24 hours, wherein application of the alternating electric field at the first frequency to the subject's brain for the period of time increases permeability of the blood brain barrier in the subject's brain, and wherein the subject's brain is tumor-free; and

administering the substance to the subject after the period of time has elapsed, wherein the increased permeability of the blood brain barrier allows the substance to cross the blood brain barrier.

10. The method of claim 9 , wherein the alternating electric field is applied at a frequency between 75 kHz and 125 kHz.

11. The method of claim 9 , wherein the period of time is at least 48 hours.

12. The method of claim 9 , wherein the alternating electric field has a field strength of at least 1 V/cm in at least a portion of the subject's brain.

13. The method of claim 9 , wherein the alternating electric field is applied at a frequency between 75 kHz and 125 kHz, and the alternating electric field has a field strength of at least 1 V/cm in at least a portion of the subject's brain.

14. The method of claim 9 , wherein the step of applying an alternating electric field to the subject's brain is implemented by applying an AC voltage to a set of electrodes.

Assignments (6)
PATENT SECURITY AGREEMENT Recorded May 4, 2024
From: NOVOCURE GMBH (SWITZERLAND)
To: BIOPHARMA CREDIT PLC
Reel/Frame 067315/0399 →
RELEASE OF SECURITY INTEREST Recorded Apr 24, 2024
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: NOVOCURE GMBH
Reel/Frame 067211/0839 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 15, 2021
From: BRAMI, CATHERINE; HERSHKOVICH, HADAS SARA; VOLOSHIN-SELA, TALI
To: NOVOCURE GMBH
Reel/Frame 055592/0128 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 15, 2021
From: HAGEMANN, CARSTEN; LOHR, MARIO; KESSLER, ALMUTH F.; BUREK, MALGORZATA; FORSTER, CAROLA
To: JULIUS-MAXIMILIANS-UNIVERSITAT WURZBURG
Reel/Frame 055592/0289 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 15, 2021
From: JULIUS-MAXIMILIANS-UNIVERSITAT WURZBURG
To: NOVOCURE GMBH
Reel/Frame 055592/0351 →
SECURITY INTEREST Recorded Nov 6, 2020
From: NOVOCURE GMBH
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 054344/0510 →